Results 221 to 230 of about 68,812 (293)

3D ex vivo platform for high‐throughput immunotherapy screening in relapsed/refractory lymphoma patients

open access: yesHemaSphere, Volume 10, Issue 9, September 2026.
Abstract Relapsed/refractory (R/R) B‐cell lymphomas (B‐NHL) remain incurable, with limited predictive biomarkers to guide immunotherapy. Preclinical platforms that faithfully preserve the immune context and the viability of patient samples are critically needed for relevant high‐throughput drug testing.
Fabien Gava   +20 more
wiley   +1 more source

A functional prognostic model predicts progression‐free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax

open access: yesHemaSphere, Volume 10, Issue 9, September 2026.
Abstract Targeted therapies have improved outcomes for patients with chronic lymphocytic leukemia (CLL); yet, not all achieve durable responses. Existing prognostic models, developed for chemoimmunotherapy, have limited predictive value for newer targeted combinations.
Johanne U. Hermansen   +24 more
wiley   +1 more source

Beyond motor recovery: Stem cell‐derived exosomes for sensory restoration and neuropathic pain relief after spinal cord injury

open access: yesIbrain, Volume 12, Issue 3, Page 330-349, Fall 2026.
Stem cell‐derived exosomes offer a promising cell‐free therapy for spinal cord injury by delivering diverse bioactive cargos. This review highlights their roles in motor recovery, sensory restoration, and neuropathic pain relief through axonal regeneration, synaptic remodeling, neural differentiation, glial metabolic reprogramming, immunomodulation ...
Md Miftahul Mithu   +8 more
wiley   +1 more source

Prospective Head‐To‐Head Comparison of a 10‐Color Single‐Tube Flow Cytometry and EuroFlow Next‐Generation Flow in Multiple Myeloma Minimal Residual Disease

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 18, September 2026.
We compared a 10‐color single‐tube (ST‐10C) assay with the EuroFlow next‐generation flow (NGF) method for detecting minimal residual disease (MRD) in multiple myeloma. The ST‐10C assay showed substantial qualitative agreement, strong quantitative correlation, and comparable progression‐free survival stratification relative to the EuroFlow NGF assay ...
Go Eun Bae   +9 more
wiley   +1 more source

Proteomics‐Based Identification of the Pyroptosis‐Related Biomarker PCSK9 and Its Association With the Pathogenesis of Rheumatoid Arthritis

open access: yesThe Kaohsiung Journal of Medical Sciences, Volume 42, Issue 9, September 2026.
ABSTRACT Rheumatoid arthritis (RA) is a common autoimmune disease, and early diagnosis is critical for effective treatment. This study aims to identify potential biomarkers related to pyroptosis through serum proteomics analysis, offering new insights for the early diagnosis of RA.
Lei Wang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy